文献速递乳腺MR

基于MRI与临床病理特征的年轻女性乳腺癌先行手术后复发预测模型

A predictive model using MRI and clinicopathologic features for breast cancer recurrence in young women treated with upfront surgery.
PubMed 文献 · Eur Radiol · 2024-05-24

回顾性分析438例35岁及以下先行手术乳腺癌女性,术前乳腺MRI由不知结局的乳腺放射科医师独立阅片。MRI肿瘤大小(HR=1.158)、多灶或多中心病变(HR=1.676)、T2WI瘤周水肿(HR=2.166)为复发独立预测因素,辅助内分泌治疗(HR=0.624)与复发呈负相关;模型预测5年复发C指数开发队列0.707、验证队列0.686,总体复发C指数开发队列0.699、验证队列0.678,校准图一致性相关系数0.903。

要点

  • MRI肿瘤大小、多灶或多中心病变、T2WI瘤周水肿为复发独立预测因素。
  • 5年复发C指数开发队列0.707、验证队列0.686,总体复发0.699与0.678。
  • 校准图一致性相关系数0.903,模型区分度与校准度良好。

核心结论

  • 基于术前乳腺MRI与临床病理特征的预测模型对先行手术年轻乳腺癌女性复发显示良好区分度,可能有助于个体化风险分层。

研究设计与样本

  • 回顾性研究,纳入2007年1月至2016年12月连续438例35岁及以下乳腺癌女性,术前乳腺MRI由对患者结局设盲的乳腺放射科医师独立阅片,结合临床病理资料行单变量和多变量logistic回归分析,开发并评估复发风险预测模型的区分度与校准度。

关键影像表现/征象

  • MRI所示肿瘤大小(HR=1.158,p=0.006)为复发独立预测因素。
  • 多灶或多中心病变(HR=1.676,p=0.017)为复发独立预测因素。
  • T2WI瘤周水肿(HR=2.166,p=0.001)为复发独立预测因素。
  • 辅助内分泌治疗(HR=0.624,p=0.035)与复发呈负相关。

诊断标准与关键数值

  • 438例中95例(21.7%)在中位随访65个月后出现复发。
  • 预测5年复发C指数:开发队列0.707,验证队列0.686。
  • 预测总体复发C指数:开发队列0.699,验证队列0.678。
  • 校准图一致性相关系数为0.903。

临床应用与阅片要点

  • 术前乳腺MRI评估肿瘤大小、多灶或多中心病变及T2WI瘤周水肿,可为年轻乳腺癌患者复发风险分层提供信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To identify preoperative breast MR imaging and clinicopathological variables related to recurrence and develop a risk prediction model for recurrence in young women with breast cancer treated with upfront surgery.

METHODS: This retrospective study analyzed 438 consecutive women with breast cancer aged 35 years or younger between January 2007 and December 2016. Breast MR images before surgery were independently reviewed by breast radiologists blinded to patient outcomes. The clinicopathological data including patient demographics, clinical features, and tumor characteristics were reviewed. Univariate and multivariate logistic regression analyses were used to identify the independent factors associated with recurrence. The risk prediction model for recurrence was developed, and the discrimination and calibration abilities were assessed.

RESULTS: Of 438 patients, 95 (21.7%) developed recurrence after a median follow-up of 65 months. Tumor size at MR imaging (HR = 1.158, p = 0.006), multifocal or multicentric disease (HR = 1.676, p = 0.017), and peritumoral edema on T2WI (HR = 2.166, p = 0.001) were identified as independent predictors of recurrence, while adjuvant endocrine therapy (HR = 0.624, p = 0.035) was inversely associated with recurrence. The prediction model showed good discrimination ability in predicting 5-year recurrence (C index, 0.707 in the development cohort; 0.686 in the validation cohort) and overall recurrence (C index, 0.699 in the development cohort; 0.678 in the validation cohort). The calibration plot demonstrated an excellent correlation (concordance correlation coefficient, 0.903).

CONCLUSION: A prediction model based on breast MR imaging and clinicopathological features showed good discrimination to predict recurrence in young women with breast cancer treated with upfront surgery, which could contribute to individualized risk stratification.

CLINICAL RELEVANCE STATEMENT: Our prediction model, incorporating preoperative breast MR imaging and clinicopathological features, predicts recurrence in young women with breast cancer undergoing upfront surgery, facilitating personalized risk stratification and informing tailored management strategies.

KEY POINTS: Younger women with breast cancer have worse outcomes than those diagnosed at more typical ages. The described prediction model showed good discrimination performance in predicting 5-year and overall recurrence. Incorporating better risk stratification tools in this population may help improve outcomes.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Chae EY, Jung MR, Cha JH, et al. A predictive model using MRI and clinicopathologic features for breast cancer recurrence in young women treated with upfront surgery. Eur Radiol. 2024. PMID: 38787429. doi:10.1007/s00330-024-10805-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。